Jorey Chernett Biography and Net Worth

Major Shareholder of Oncology Institute

Jorey Chernett is the CEO, founder, developer, and marketer of Authentic4D. Jorey has a passion for building and investing in businesses. Jorey previously served as President of D4D Technologies, LLC, a medical device company providing 3D imaging and CNC milling solutions to the $60B dental crown and bridge industry. He led the company inarchitecting and executing its business model, taking D4D through key strategic partnerships, culminating in a sale to strategic investors that included 3M and Henry Schein. Jorey’s past includes experience as a venture capitalist (Illinois Ventures, LLC/Camelot), operator (DigitalWork, Inc.) and investment banker (Donaldson Lufkin & Jenrette). He received his Bachelor of Science degree in Finance with honors from Indiana University.

What is Jorey Chernett's net worth?: The estimated net worth of Jorey Chernett is at least $38.18 million as of April 20th, 2026. Mr. Chernett owns 9,878,988 shares of Oncology Institute stock worth more than $38,182,289 as of April 30th. This net worth approximation does not reflect any other assets that Mr. Chernett may own. Learn More about Jorey Chernett's net worth.
How do I contact Jorey Chernett?: The corporate mailing address for Mr. Chernett and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Jorey Chernett's contact information.
Has Jorey Chernett been buying or selling shares of Oncology Institute?: During the last ninety days, Jorey Chernett has bought $62,000.00 in shares of Oncology Institute stock. Most recently, on Thursday, April 9th, Jorey Chernett bought 20,000 shares of Oncology Institute stock. The stock was acquired at an average cost of $3.10 per share, with a total value of $62,000.00. Following the completion of the transaction, the insider now directly owns 10,499,358 shares of the company's stock, valued at $32,548,009.80. Learn More on Jorey Chernett's trading history.
Who are Oncology Institute's active insiders?: Oncology Institute's insider roster includes Jorey Chernett (Major Shareholder), Brad Hively (Director), Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.
Are insiders buying or selling shares of Oncology Institute?: In the last year, Oncology Institute insiders bought shares 6 times. They purchased a total of 568,985 shares worth more than $1,759,600.65. In the last year, insiders at the sold shares 12 times. They sold a total of 11,585,436 shares worth more than $34,668,174.42. The most recent insider tranaction occured on April, 16th when Director Mohit Kaushal sold 38,433 shares worth more than $134,515.50. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.
Information on this page was last updated on 4/16/2026.

Jorey Chernett Insider Trading History at Oncology Institute

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/9/2026	Buy	20,000	$3.10	$62,000.00	10,499,358
3/24/2026	Buy	125,000	$3.11	$388,750.00	10,401,929
3/20/2026	Buy	25,000	$3.35	$83,750.00	10,276,929
3/17/2026	Buy	75,000	$3.42	$256,500.00	10,251,929
3/16/2026	Buy	60,985	$3.29	$200,640.65	10,176,929
3/13/2026	Buy	263,000	$2.92	$767,960.00	10,115,944

Jorey Chernett Buying and Selling Activity at Oncology Institute

Oncology Institute Company Overview

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Today's Range

Now: $3.86

$3.66

$3.91

50 Day Range

MA: $3.10

$2.55

$3.71

2 Week Range

Now: $3.86

$2.02

$4.88

Volume

1,521,954 shs

Average Volume

1,898,429 shs

Market Capitalization

$381.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17